Semaglutide has rapidly become a leading medication in the treatment of type 2 diabetes and weight management. Known for its efficacy in improving glycemic control and promoting weight loss, Semaglutide is a GLP-1 (Glucagon-Like Peptide-1) receptor agonist that has garnered significant attention in the medical community. This article delves into the specifics of Semaglutide, including its chemical identifiers, its role in therapy, and its significance in modern medicine.
Every chemical compound is assigned a unique identifier known as a CAS (Chemical Abstracts Service) number. For Semaglutide, this number is **CAS 910463-68-2**. This identifier is crucial for researchers, pharmacists, and healthcare providers as it allows for the precise identification of the compound in scientific literature and commercial applications. The Semaglutide CAS number, 910463-68-2, helps ensure that the correct substance is used in formulations and therapeutic practices, maintaining the integrity and safety of medical treatments.
Semaglutide is primarily used as a treatment for type 2 diabetes, where it functions by mimicking the effects of the GLP-1 hormone. This hormone plays a key role in regulating blood sugar levels by stimulating insulin secretion and inhibiting glucagon release. In addition to its impact on glucose metabolism, Semaglutide also slows gastric emptying, which helps reduce appetite and contribute to weight loss. Its effectiveness has made it a valuable option for both diabetes management and weight reduction, with many patients experiencing significant improvements in their overall health.
The specific CAS number 910463-68-2 associated with Semaglutide is not just a technical detail; it represents the compound’s unique chemical structure and properties. This identifier is used extensively in research and development, ensuring that studies on Semaglutide are accurate and consistent. By referencing the Semaglutide CAS number, scientists can trace the compound’s origins, verify its purity, and explore its potential applications beyond current uses. This precision is vital in advancing medical knowledge and expanding the therapeutic uses of Semaglutide.
Semaglutide, identified by its CAS 910463-68-2, continues to revolutionize the treatment landscape for type 2 diabetes and obesity. Its unique properties as a GLP-1 receptor agonist have made it a cornerstone in modern therapy, offering hope to millions of patients worldwide. Understanding its chemical identifiers and therapeutic role underscores the importance of Semaglutide in both current medical practice and future research.